{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:25:54Z","timestamp":1793917554945,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ventricular tachycardia (VT) ablation in arrhythmogenic right ventricular cardiomyopathy (ARVC) is typically performed using an endocardial first approach. However, epicardial involvement is common and recurrence remains frequent. We therefore compared the pooled efficacy and safety of endocardial-only versus combined endocardial and epicardial ablation strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a systematic review and Bayesian meta-analysis of studies comparing endocardial and endo-epicardial VT ablation in patients with ARVC, including single- and double-arm designs. Ventricular arrhythmia (VA) recurrence was the primary endpoint and major complications were secondary. Bayesian methods were used to estimate pooled odds ratios (ORs) with 95% credible intervals (CrIs), with posterior predictive checks assessing model fit. A frequentist random-effects meta-analysis of double-arm studies was also conducted. Individual patient data (IPD) reconstructed from Kaplan\u2013Meier curves enabled pooled survival analyses and hazard ratio (HR) estimation for VA recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventeen studies including 976 patients reporting primary or secondary outcomes were analyzed. Endo-epicardial ablation in ARVC was associated with a significantly lower risk of ventricular arrhythmia (VA) recurrence (Bayesian OR 0.47, 95% CrI 0.34\u20130.64), with similar frequentist analysis results (OR 0.48, 95% CI 0.30\u20130.75,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Reconstructed IPD from 460 patients showed reduced VA recurrence (HR 0.39, 95% CI 0.28\u20130.52; log-rank\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Across 15 studies (866 patients), the combined approach increased complication risk (Bayesian OR 6.28, 95% CI 2\u201324). The frequentist model demonstrated a comparable increase (OR 3.19, 95% CI 1.02\u201310,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.047).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Endo-epicardial ablation reduced VA recurrence but increased major complication risk compared with endocardial ablation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10840-026-02348-0","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:19:09Z","timestamp":1778476749000},"page":"2425-2437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of endocardial versus endo-epicardial catheter ablation for ventricular arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy: a meta analysis"],"prefix":"10.1007","volume":"69","author":[{"given":"Ashish","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshat","family":"Banga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawai Singh","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ashraf","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Maan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kevin","family":"Heist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"2348_CR1","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","volume":"121","author":"FI Marcus","year":"2010","unstructured":"Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533\u201341.","journal-title":"Circulation"},{"key":"2348_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","volume":"54","author":"GM Marcus","year":"2009","unstructured":"Marcus GM, Glidden DV, Polonsky B, et al. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol. 2009;54:609\u201315.","journal-title":"J Am Coll Cardiol"},{"key":"2348_CR3","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1161\/CIRCULATIONAHA.104.510503","volume":"111","author":"A Verma","year":"2005","unstructured":"Verma A, Kilicaslan F, Schweikert RA, et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation. 2005;111:3209\u201316.","journal-title":"Circulation"},{"key":"2348_CR4","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1161\/01.CIR.0000145154.02436.90","volume":"110","author":"FE Marchlinski","year":"2004","unstructured":"Marchlinski FE, Zado E, Dixit S, et al. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation. 2004;110:2293\u20138.","journal-title":"Circulation"},{"key":"2348_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","volume":"120","author":"FC Garcia","year":"2009","unstructured":"Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia. Circulation. 2009;120:366\u201375.","journal-title":"Circulation"},{"key":"2348_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1161\/CIRCEP.111.963066","volume":"4","author":"R Bai","year":"2011","unstructured":"Bai R, Di Biase L, Shivkumar K, et al. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate-based mapping and ablation. Circ Arrhythm Electrophysiol. 2011;4:478\u201385.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2348_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/CIRCEP.110.960799","volume":"4","author":"MI Scanavacca","year":"2011","unstructured":"Scanavacca MI, Venancio AC, Pisani CF, et al. Percutaneous transatrial access to the pericardial space for epicardial mapping and ablation. Circ Arrhythm Electrophysiol. 2011;4:331\u20136.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2348_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/jce.12058","volume":"24","author":"JS Bradfield","year":"2013","unstructured":"Bradfield JS, Tung R, Boyle NG, Buch E, Shivkumar K. Our approach to minimize risk of epicardial access: standard techniques with the addition of electroanatomic mapping guidance. J Cardiovasc Electrophysiol. 2013;24:723\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2348_CR9","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCEP.115.002827","volume":"8","author":"M Izquierdo","year":"2015","unstructured":"Izquierdo M, S\u00e1nchez-G\u00f3mez JM, Ferrero de Loma-Osorio A, et al. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease. Circ Arrhythm Electrophysiol. 2015;8:882\u20139.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2348_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"2348_CR11","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"issue":"1","key":"2348_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","volume":"21","author":"N Liu","year":"2021","unstructured":"Liu N, Zhou Y, Lee JJ. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2021;21(1):111. https:\/\/doi.org\/10.1186\/s12874-021-01308-8. Published 2021 Jun 1.","journal-title":"BMC Med Res Methodol"},{"key":"2348_CR13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jacc.2007.03.049","volume":"50","author":"D Dalal","year":"2007","unstructured":"Dalal D, Jain R, Tandri H, et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy. J Am Coll Cardiol. 2007;50:432\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2348_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/CIRCEP.111.968677","volume":"5","author":"B Philips","year":"2012","unstructured":"Philips B, Madhavan S, James C, et al. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Circ Arrhythm Electrophysiol. 2012;5(3):499\u2013505. https:\/\/doi.org\/10.1161\/CIRCEP.111.968677.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"2348_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/CIRCEP.110.960740","volume":"5","author":"A Berruezo","year":"2012","unstructured":"Berruezo A, Fern\u00e1ndez-Armenta J, Mont L, et al. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol. 2012;5(1):111\u201321. https:\/\/doi.org\/10.1161\/CIRCEP.110.960740.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"2348_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","volume":"8","author":"P Santangeli","year":"2015","unstructured":"Santangeli P, Zado ES, Supple GE, et al. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8(6):1413\u201321. https:\/\/doi.org\/10.1161\/CIRCEP.115.003562.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"2348_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/jce.12858","volume":"27","author":"B Berte","year":"2016","unstructured":"Berte B, Sacher F, Venlet J, et al. VT Recurrence After Ablation: Incomplete Ablation or Disease Progression? A Multicentric European Study. J Cardiovasc Electrophysiol. 2016;27(1):80\u20137. https:\/\/doi.org\/10.1111\/jce.12858.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"2348_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10840-016-0209-3","volume":"48","author":"A M\u00fcssigbrodt","year":"2017","unstructured":"M\u00fcssigbrodt A, Efimova E, Knopp H, et al. Should all patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy undergo epicardial catheter ablation? J Interv Card Electrophysiol. 2017;48(2):193\u20139. https:\/\/doi.org\/10.1007\/s10840-016-0209-3.","journal-title":"J Interv Card Electrophysiol"},{"issue":"1","key":"2348_CR19","doi-asserted-by":"publisher","first-page":"e0169863","DOI":"10.1371\/journal.pone.0169863","volume":"12","author":"W Wei","year":"2017","unstructured":"Wei W, Liao H, Xue Y, et al. Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience. PLoS ONE. 2017;12(1):e0169863. https:\/\/doi.org\/10.1371\/journal.pone.0169863. Published 2017 Jan 25.","journal-title":"PLoS ONE"},{"issue":"4","key":"2348_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/europace\/euw212","volume":"19","author":"A Berruezo","year":"2017","unstructured":"Berruezo A, Acosta J, Fern\u00e1ndez-Armenta J, et al. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study. Europace. 2017;19(4):607\u201316. https:\/\/doi.org\/10.1093\/europace\/euw212.","journal-title":"Europace"},{"issue":"1","key":"2348_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jacep.2018.09.019","volume":"5","author":"P Santangeli","year":"2019","unstructured":"Santangeli P, Tung R, Xue Y, et al. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry. JACC Clin Electrophysiol. 2019;5(1):55\u201365. https:\/\/doi.org\/10.1016\/j.jacep.2018.09.019.","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"2348_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.hrthm.2018.10.016","volume":"16","author":"S Mahida","year":"2019","unstructured":"Mahida S, Venlet J, Saguner AM, et al. Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: Results from a multicenter study. Heart Rhythm. 2019;16(4):536\u201343. https:\/\/doi.org\/10.1016\/j.hrthm.2018.10.016.","journal-title":"Heart Rhythm"},{"issue":"5","key":"2348_CR23","doi-asserted-by":"publisher","first-page":"e010365","DOI":"10.1161\/JAHA.118.010365","volume":"8","author":"S Mathew","year":"2019","unstructured":"Mathew S, Saguner AM, Schenker N, et al. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy\/Dysplasia: A Sequential Approach. J Am Heart Assoc. 2019;8(5):e010365. https:\/\/doi.org\/10.1161\/JAHA.118.010365.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"2348_CR24","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/europace\/euab172","volume":"23","author":"E Gandjbakhch","year":"2021","unstructured":"Gandjbakhch E, Laredo M, Berruezo A, et al. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy. Europace. 2021;23(9):1428\u201336. https:\/\/doi.org\/10.1093\/europace\/euab172.","journal-title":"Europace"},{"issue":"8","key":"2348_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.hrthm.2021.04.028","volume":"18","author":"UA Daimee","year":"2021","unstructured":"Daimee UA, Assis FR, Murray B, et al. Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: Insights from the Johns Hopkins ARVC Program. Heart Rhythm. 2021;18(8):1369\u201376. https:\/\/doi.org\/10.1016\/j.hrthm.2021.04.028.","journal-title":"Heart Rhythm"},{"key":"2348_CR26","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.jacep.2024.05.003","volume":"10","author":"C Chaumont","year":"2024","unstructured":"Chaumont C, Tschabrunn CM, Oraii A, et al. Long-term freedom from ventricular arrhythmias in ARVC with endocardial only ablation: Predictors of success. JACC Clin Electrophysiol. 2024;10:1551\u201361.","journal-title":"JACC Clin Electrophysiol"},{"key":"2348_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1540-8167.2009.01544.x","volume":"21","author":"C Grimard","year":"2010","unstructured":"Grimard C, Lacotte J, Hidden-Lucet F, Duthoit G, Gallais Y, Frank R. Percutaneous epicardial radiofrequency ablation of ventricular arrhythmias after failure of endocardial approach: a 9-year experience. J Cardiovasc Electrophysiol. 2010;21:56\u201361.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2348_CR28","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1161\/01.CIR.0000087407.53326.31","volume":"108","author":"RA Schweikert","year":"2003","unstructured":"Schweikert RA, Saliba WI, Tomassoni G, et al. Percutaneous pericardial instrumentation for endo-epicardial mapping of previously failed ablations. Circulation. 2003;108:1329\u201335.","journal-title":"Circulation"},{"key":"2348_CR29","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/jce.15101","volume":"32","author":"J Romero","year":"2021","unstructured":"Romero J, Patel K, Lakkireddy D, et al. Epicardial access complications during electrophysiology procedures. J Cardiovasc Electrophysiol. 2021;32:1985\u201394.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2348_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jacep.2023.09.007","volume":"10","author":"M Raad","year":"2024","unstructured":"Raad M, Supple GE. Epicardial ventricular tachycardia ablation: Patient selection, access and ablation techniques and strategies to manage complications. JACC Clin Electrophysiol. 2024;10:142\u201364.","journal-title":"JACC Clin Electrophysiol"},{"key":"2348_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.CIR.94.5.983","volume":"94","author":"C Basso","year":"1996","unstructured":"Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94:983\u201391.","journal-title":"Circulation"},{"key":"2348_CR32","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/europace\/euw062","volume":"19","author":"S Kirubakran","year":"2017","unstructured":"Kirubakran S, Bisceglia C, Silberbauer J, et al. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation. Europace. 2017;19:1049\u201362.","journal-title":"Europace"},{"key":"2348_CR33","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jacc.2019.12.044","volume":"75","author":"R Tung","year":"2020","unstructured":"Tung R, Raiman M, Liao H, et al. Simultaneous endocardial and epicardial delineation of 3 D reentrant ventricular tachycardia. J Am Coll Cardiol. 2020;75:884\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"2348_CR34","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jacep.2018.05.011","volume":"4","author":"JM Sellal","year":"2018","unstructured":"Sellal JM, Magnin-Poull I, Battagia A, et al. First simultaneous endocardial and epicardial mapping of a ventricular tachycardia in an ARVD\/C patient. JACC Clin Electrophysiol. 2018;4:1265\u20137.","journal-title":"JACC Clin Electrophysiol"},{"key":"2348_CR35","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCEP.111.965731","volume":"4","author":"JS Koruth","year":"2011","unstructured":"Koruth JS, Aryana A, Dukkipati SR, et al. Unusual complications of percutaneous epicardial access and epicardial mapping and ablation of cardiac arrhythmias. Circ Arrhythm Electrophysiol. 2011;4:882\u20138.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"2348_CR36","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/jce.14593","volume":"31","author":"J Romero","year":"2020","unstructured":"Romero J, Patel K, Briceno D, et al. Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2020;31(8):2022\u201331. https:\/\/doi.org\/10.1111\/jce.14593.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"2348_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jacep.2018.08.010","volume":"5","author":"J Romero","year":"2019","unstructured":"Romero J, Cerrud-Rodriguez RC, Di Biase L, et al. Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for Ventricular Tachycardia in Structural Heart Disease: A Systematic Review and Meta-Analysis. JACC Clin Electrophysiol. 2019;5(1):13\u201324. https:\/\/doi.org\/10.1016\/j.jacep.2018.08.010.","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02348-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02348-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02348-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:04:10Z","timestamp":1793916250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02348-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["2348"],"URL":"https:\/\/doi.org\/10.1007\/s10840-026-02348-0","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Since this is a network meta-analysis of previously published studies and does not involve any new human or animal research, it was exempt from Institutional Review Board (IRB) approval.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"While preparing this work, the authors used Grammarly to improve the language and grammar of the text. After using this tool\/service, the authors reviewed and edited the content as needed and took full responsibility for the publication's content.","order":3,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AM: Consulting: Biotronik, Mariana AI, Vektor Medical Inc. EKH: Consulting: Biotronik, Boston Scientific, Future Cardia","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}